GlassScriptPhysician profile
Michael J Kaiser
NPI 1437260874
$3,866.28
in general payments reported to CMS, 2019-2025
11 companies · $2,419 in 2025
The $2,419 reported for 2025 was more than what 97% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $392 · 2023: $749 · 2024: $307 · 2025: $2,419.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,004 · Food and Beverage: $1,471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,003.50 |
| Food and Beverage | $1,471.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,243.03 | 2025 | Venapax, Traumaone, Ribfix Blu Advantage |
| Getinge USA Sales, LLC | $455.62 | 2023 | Vasoview Hemopro 2 |
| Abiomed | $310.78 | 2022-2024 | Impella |
| Artivion, INC. | $238.05 | 2022-2024 | Amds-Ascyrus Medical, Cryovalve Sg Pulmonary Human Heart Valve |
| Atricure, INC. | $230.94 | 2023-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2) |
| Davol INC. | $187.89 | 2023 | Progel Applicator Spray Tips, Arista Ah Flexitip |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $75.19 | 2022-2024 | Lifevest |
| Edwards Lifesciences Corporation | $58.44 | 2024 | Evoque, Pascal |
| Kci USA, INC. | $33.49 | 2023 | Prevena, V.A.C. Veraflo |
| Cvrx, INC. | $18.88 | 2024 | Barostim Neo System |
| Pfizer INC. | $13.97 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kaiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.